Exjade, the first ORAL iron-chelation therapy
December 2006
Health Canada has approved Exjade, the first ORAL iron-chelation therapy.
Patients who need transfusions for blood disorders... thalassemia, sickle cell disease, etc...often develop iron overload.
High levels of iron can be toxic to the heart and liver.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 300+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive